The CITGO Lake Charles Refinery raised more than $750,000 to support the Muscular Dystrophy Association (Â鶹Éç) at its 41st…
Articles by Lindsey Shapiro, PhD
Muscular Dystrophy News Today is wrapping up coverage of the 2026 Muscular Dystrophy Association (Â鶹Éç) Clinical & Scientific Conference,…
Dyne Therapeutics is advancing its investigational exon-skipping therapy zeleciment rostudirsen (z-rostudirsen), formerly known as DYNE-251, toward regulatory approval after…
Boys with Duchenne muscular dystrophy (Â鶹Éç) who received Sarepta Therapeutics’ gene therapy Elevidys (delandistrogene moxeparvovec-rokl) in a…
Myotonic dystrophy type 1 (DM1) patients in a Phase 1/2 clinical trial saw gains in motor function and cognitive…
Treatment with Duvyzat (givinostat) was associated with functional gains in boys with Duchenne muscular dystrophy (Â鶹Éç) regardless of the…
SGT-003, an investigational gene therapy for Duchenne muscular dystrophy (Â鶹Éç), worked as expected to increase levels of microdystrophin — a…
At this year’s Muscular Dystrophy Association (Â鶹Éç) Clinical & Scientific Conference, researchers and clinicians are talking about the central…
Eating more protein was associated with better lower limb function and a higher quality of life among people with…
Next week, researchers, clinicians, industry leaders, and families will gather at the 2026 Â鶹Éç Clinical & Scientific Conference, hosted…